From September 29th to October 1st 2014, the 2nd Colloquium of the DFG Priority Program 1681: Field controlled particle matrix interactions: synthesis multi-scale modelling and application of magnetic- hybrid materials was held in the Bavarian cloister Benediktbeuern. This colloquium is part of a special program of the German Research Foundation (DFG) (i.e., DFG Priority Program 1681) that started in January 2014 and is focused on novel magnetic hybrid materials research. The research ranges from production to technical and medical applications and includes modelling of field dependent interaction with different matrices. The work benefits from the cross-specialization collaboration of chemists, physicist, engineers, biologists, and medics.
Nearly 9 months after the start of the program, more than 60 scientists from each of the 27 projects in the program presented their most recent research findings in scientific talks and posters. The scientific reports presented during the colloquium showed very promising results. The highlight of the three-day meeting was a hiking tour in the mountains that culminated in scientific presentations being given in an alpine hut (without any projection equipment). For the selected presenters, it was an honor to speak in this unusual setting as its technical limitations require extra clarity in the communication of results.
The next colloquium will take place at the end of September 2015 at which time the first 2-year funding period will be coming to a close and groups will be looking to apply for more funding on the basis of their results.
Link to SPP description: http://www.mfd.mw.tu-dresden.de/spp1681/index.php/willkommen
Environmental conditions, such as heat, acidity, and mechanical forces, can affect the behavior of cells. Some biologists have even shown that magnetic fields can influence them. Now, for the first time, an international team reports that low-strength magnetic fields may foster the reprogramming of cellular development, aiding in the transformation of adult cells into pluripotent stem cells (ACS Nano 2014, DOI: 10.1021/nn502923s). If confirmed, the phenomenon could lead to new tools for bioengineers to control cell fates and help researchers understand the potential health effects of changing magnetic fields on astronauts.
Biologists have been building up evidence that magnetic fields affect living things, says Michael Levin, director of Tufts University’s Center for Regenerative & Developmental Biology, who was not involved in the new study. For example, plants and amphibian embryos develop abnormally when shielded from Earth’s geomagnetic field. And there’s some clinical evidence that particular electromagnetic frequencies promote bone fracture healing and wound repair (Eur. Cytokine Network 2013, DOI: 10.1684/ecn.2013.0332).
Tests that look for biomarkers could help physicians diagnose disease before symptoms present themselves. But it’s difficult to find the right protein, metabolite, or other molecule in the body that signals the start of a disease. Now researchers have described a sensitive new assay that generates its own synthetic biomarkers to detect harmful blood clots in mice (J. Am. Chem. Soc. 2014, DOI: 10.1021/ja505676h).
Unfortunately, natural biomarkers that are both specific to a disease and easy to detect are relatively rare. So Sangeeta N. Bhatia of Massachusetts Institute of Technology and David R. Walt of Tufts University decided to develop an assay that caused diseased cells or tissues to produce a synthetic molecule the scientists could easily find.
To create the assay, the scientists combined technologies their two groups had been working on: Bhatia’s group had synthesized worm-shaped iron oxide nanoparticles that they decorated with molecules to home in on diseased cells, while Walt’s team had developed single-molecule arrays (SiMoA) that allowed them to detect extremely low quantities of biological compounds of interest. For the new assay, the two teams decorated the nanoworms with a peptide that can be cleaved by thrombin, an enzyme activated at high levels in clotting disorders. When the nanoparticles bump into active thrombin in a mouse with clotting problems, the enzymes clip off a labeled peptide that the mice then excrete in their urine.
A new technique that forms and controls magnetically responsive liquid crystals could be applied to many types of displays. Conventional liquid crystals, often used in electronic displays, are composed of tiny rod-like molecules. Researchers at the University of California, Riverside, have created crystal nanorods that rotate and realign themselves parallel to nearby magnetic fields.
“We utilized our expertise in colloidal nanostructure synthesis to produce magnetite nanorods that can form liquid crystals and respond strongly to even very weak magnetic fields,” said lead researchers Dr. Yadong Yin, an associate professor of chemistry at the university. “Even a fridge magnet can operate our liquid crystals.”
The nanorods can also form patterns to control the transmittance of polarized light in selected areas. “Such a thin film does not display visual information under normal light, but shows high contrast patterns under polarized light,” Yin said, noting that this is not possible with commercial liquid crystals.
The new liquid crystals could be used in applications such as signs and displays, optical modulation and anti-counterfeiting efforts, the researchers said. The research was published in Nano Letters (doi: 10.1021/nl501302s).
The increase in clinical trials assessing the efficacy of cell therapy for structural and functional regeneration of the nervous system in diseases related to the aging brain is well known. However, the results are inconclusive as to the best cell type to be used or the best methodology for the homing of these stem cells. Alvarim et al wrote a systematic review that analyzes published data on SPION (superparamagnetic iron oxide nanoparticle)-labeled stem cells as a therapy for brain diseases, such as ischemic stroke, Parkinson’s disease, amyotrophic lateral sclerosis, and dementia. Their review highlights the therapeutic role of stem cells in reversing the aging process and the pathophysiology of brain aging, as well as emphasizes nanotechnology as an important tool to monitor stem cell migration in affected regions of the brain.
Check it out here.
Every year, Magnetics Technology International publishes an annual issue. This journal, which describes itself as "The world's leading global review dedicated to advanced magnetics and magnet technologies" is quite interesting. This year, it for example contains stories about magnetic stimulation of the brain, cerium in high energy magnets, precision magnetic field mapping, the synthesis of FePt nanoparticles for use in high-density data storage, and magnetic nanopeapod composites. Amongst many more good articles!
Check it out at http://viewer.zmags.com/publication/2235d3a9#/2235d3a9/3.
In a strategy known as gene therapy, scientists insert engineered DNA into diseased cells in order to treat or kill them. Now, researchers have combined nanotechnology and synthetic biology to create a simple switch to turn on such genes inside cells. They demonstrate that heat generated by magnetic nanoparticles activates the engineered genes, slowing tumor growth in mice (ACS Synth. Biol. 2013, DOI: 10.1021/sb4000838).
For gene therapy to reach clinical applications, such as for treating cancer, researchers need to activate their engineered gene sequences only in the diseased cells. That’s because in the course of introducing the synthetic genes, some healthy cells also may pick up the DNA packages. So to prevent activating synthetic genes in healthy cells, researchers want to design genetic circuits that can be triggered selectively.
Currently, there are only a few ways to do that, typically through applying drugs to the cells. Masamichi Kamihira of Kyushu University, in Japan, and his colleagues thought magnetic fields would be a more useful trigger. The fields travel deep into tissues and can be targeted to certain areas of tissue to avoid turning on genes in healthy cells.
Magnetite nanoparticles surrounded by a cationic liposome (see above, left) generate heat when an alternating magnetic field is applied. Inside a cancer cell, the heat (thick red arrow) activates a promoter region (pink, P) in an engineered gene sequence containing instructions for a cell-killing protein (blue, TNF-α). The heat promoter also turns on a gene for a protein called tTA (orange) that activates a second response element (green, TRE) to continually express TNF-α. A sequence in-between (purple, IRES) ensures that both genes get translated into proteins.
Maxim and Petr Nikitin and colleagues just published a beautiful paper in the September issue of Nature Nanotechnology. They were even chosen for the cover picture. Check their paper out here.
They explored the computing potential of particle-based systems. They were able to show that almost any type of nanoparticle or microparticle can be transformed into autonomous biocomputing structures that are capable of implementing a functionally complete set of Boolean logic gates (YES, NOT, AND and OR) and binding to a target as result of a computation. The logic-gating functionality was incorporated into self-assembled particle/biomolecule interfaces (demonstrated in their work with proteins) and the logic gating was achieved through input-induced disassembly of the structures. To illustrate the capabilities of the approach, they showed that the structures can be used for logic-gated cell targeting and advanced immunoassays.
Maxim and Petr used magnetic nanoparticles with a diameter of about 100 nm for their work, and detected the particles with their own non-linear magnetization method (MPQ).
The proposed platform can be applied to the development of autonomous nanodevices as intelligent biosensors with built-in biochemical data analysis for multiplex point-of care diagnostics, field testing and so on. Furthermore, with the progress in metabolomics for the identification of new small molecule biomarkers, the platform could be used to construct bionanorobotic agents for complex stimuli-controlled targeted drug delivery, early diagnostics and health monitoring as a part of preventive medicine solutions.
For more information, check out our Archives.